NFE2L2 and neoplasm: Meanwhile, Kras mutation is reported to augment Nrf2 mRNA levels in tumor cells [6] and subsequently, to induce strong anti-oxidation and metabolic adaptation in KLK LUAD cells in favor of their survival [5].